NEW YORK (GenomeWeb) – The National Institutes of Health this week proposed receiving an additional $323 million in Alzheimer’s disease funding over what has already been budgeted for the agency in fiscal 2017, stating that the additional money would significantly accelerate research into a disease that is expected to affect more than 65 million people worldwide by 2030.

“While we have made significant progress in our understanding of the mechanisms of Alzheimer’s disease, there currently is no cure, and no treatments have been conclusively proven to prevent or delay its course,” NIH Director Francis Collins said in a statement. “We believe that if we expand and build upon our base of scientific knowledge, we can identify and implement the strategies for combating Alzheimer’s disease that are so desperately needed.”

View Full Article